Introduction {#sec1-1}
============

Parvovirus B19 is known to cause clinical syndromes such as erythema infectiosum, aplastic crisis, and arthropathy.\[[@ref1]\] However, most infections in adults are subclinical.\[[@ref2][@ref3]\] Here, we report a patient with fever and symmetric polyarthritis, later identified as acute polyarthritis due to parvovirus B19.

Case Presentation {#sec1-2}
=================

A 65-year-old lady from Southern India presented with high-grade fever and joint pain with early morning stiffness for 10 days. She developed pain and swelling in metacarpophalangeal and proximal interphalangeal joints of both hands on day 4 of illness with sparing of distal interphalangeal joints. On day 5, she developed swelling and pain of bilateral knees followed by similar symptoms in both ankles on day 7, in an additive fashion.

She denied history of backache, breathlessness, uveitis, diarrhea, dysuria, rashes, weight loss, and consumption of unpasteurized milk. There was no history suggestive of connective tissue disorder or similar episodes in the past. She was febrile and tachycardic at admission (temperature: 102 F, pulse rate: 112/min). Arthritis involving bilateral proximal interphalangeal and metacarpophalangeal joints was present. The right knee and left mid-foot joints were swollen. Tender joint count was 21. Swollen joint count was 18. Examination of the abdomen, cardiovascular, and respiratory systems were unremarkable.

We made a syndromic diagnosis of acute febrile illness with symmetric polyarthritis. Differential diagnoses considered were noninfectious causes such as index presentation of rheumatoid arthritis, reactive arthritis, and mixed connective tissue disorder. Infectious etiologies such as viral arthritis (chikungunya/parvovirus B19 arthritis), Poncet\'s disease, and disseminated *Brucella/Staphylococcus* infections were also considered.

Investigations revealed leucocytosis with elevated inflammatory markers \[[Table 1](#T1){ref-type="table"}\]. Blood chemistries (electrolytes, liver, and renal function tests) were normal. X-rays of affected joints revealed effusion without chondrocalcinosis or erosions.

###### 

Relevant laboratory investigations

  Test                          Result         Normal range
  ----------------------------- -------------- ------------------
  White blood cells             11,300/µL      4,400-1,1000/µL
   Neutrophils                  78%            40%-70%
   Lymphocytes                  10%            20%-40%
   Monocytes                    9%             2%-6%
   Eosinophils                  2%             1%-6%
   Basophils                    1%             1%-2%
  Hemoglobin                    10.9 g/dL      12-15g/dL
  Platelets                     260×10^3^/µL   150-450×10^3^/µL
  ESR (mm/h)                    76             0-20
  CRP (mg/L)                    60             \<3
  Calcium (mg/dL)               9.2            8.5-10.2
  Phosphorus (mg/dL)            3.4            2.5-4.4
  Rheumatoid factor (IU/mL)     2              \<15
  ANA                           Negative       Negative
  Anti-CCP (IU/mL)              0              \<20
  Anti-streptolysin O (IU/mL)   140            \<200

ESR: Erythrocyte sedimentation rate; CRP: C-reactive protein; ANA: Antinuclear antibody; CCP: C-reactive protein

Serology for rheumatoid arthritis, chikungunya (IgM), and *Brucella* (IgM) was negative. Serial blood cultures revealed no growth. Parvovirus B19 IgM ELISA sent during her evaluation tested positive.

She was initiated on nonsteroidal anti-inflammatory drugs. Fever resolved in 5 days followed by resolution of joint symptoms over the next 5 days. At 3-month follow-up visit, she was well, with nodeformities or restriction of joint mobility.

Discussion {#sec1-3}
==========

Clinical manifestations of parvovirus B19 include hydrops fetalis, erythema infectiosum in children, and aplastic crisis in those with hemolytic anemia/lymphoproliferative disorders.\[[@ref2][@ref4]\] Clinical features may vary across different regions. [Table 2](#T2){ref-type="table"} highlights the clinical profile of acute parvovirus infections in India.

###### 

Clinical profile of acute parvovirus B19 infections in India

  Author                                  Patient population                                                                                    Clinical features                                                             IgM positive   IgG positive   PCR positive   Course and outcome
  --------------------------------------- ----------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------- -------------- -------------- -------------- -----------------------------------------------------------------------------------------------------
  Ramanathan et al. (2018)\[[@ref14]\]    Children with malignancies with clinical features of parvovirus infection/cytopenia/hemoglobin drop   \-                                                                            \-             \-             45% (27/59)    All children treated with intravenous immunoglobulin; persistent parvoviremia - 30%; died - 37%
  Viswanathan et al. (2017)\[[@ref15]\]   100 immunocompetent pregnant women without hemoglobinopathy                                           Fever and rash in 2/3 with IgM positivity; rest asymptomatic                  3% (3/100)     43% (43/100)   \-             All with acute parvovirus infection had normal pregnancy outcome
  Gupta et al. (2013)\[[@ref16]\]         66 children with aplastic anemia                                                                      All asymptomatic                                                              25% (17/66)    \-             27% (18/66)    20 children followed up for 6 months; all with acute parvovirus infection survived
  Mishra et al. (2012)\[[@ref17]\]        14 immunocompetent male adults with hemophagocytic lymphohistiocytosis                                \-                                                                            14% (2/14)     0              14% (2/14)     Alive - 1; died - 1
  Kishore et al. (2011)\[[@ref18]\]       35 children with newly diagnosed hematological malignancies                                           Erythema infectiosum - 1; maculopapular rash in legs - 1; rest asymptomatic   17% (6/35)     34% (12/35)    5% (2/35)      All with parvovirus infection survived; prolonged anemia, increased blood transfusion in IgM+ group

Although usually asymptomatic in adults, parvovirus B19 infection can occasionally result in symmetric polyarthritis.\[[@ref5]\] Differential diagnoses to be entertained include rheumatoid arthritis, systemic lupus erythematosus, and polymyalgia rheumatica.\[[@ref6]\] Joint symptoms are immunologically mediated and associated with appearance of antibodies. In a review of patients with acute undifferentiated arthropathy, parvovirus B19 IgM positivity was 14%.\[[@ref7][@ref8]\]

Parvovirus arthritis involves the metacarpophalangeal joints (75%), knees (65%), wrists (55%), and ankles (40%) and is nonerosive.\[[@ref9]\]

Distinction between acute parvovirus arthritis and index presentation of rheumatoid arthritis is imperative for prognostication and initiation of appropriate therapy \[[Table 3](#T3){ref-type="table"}\].

###### 

Clinical features and laboratory tests in rheumatoid arthritis and parvovirus B19 arthritis

  Feature                                                         Rheumatoid arthritis          Parvovirus B19 arthritis
  --------------------------------------------------------------- ----------------------------- --------------------------
  Peak incidence                                                  50-75 years                   6-19 years
  Pattern of joint Involvement                                    Small and large               Small \> large
  Number of joints                                                Polyarthritis                 Polyarthritis
  Presentation                                                    Additive                      Additive
  Clinical course                                                 Chronic                       Acute (\<6 weeks)
  Erosions and deformities                                        Present                       Absent
  Nodules                                                         Rheumatoid nodules            None
  ESR, CRP                                                        Elevated                      Elevated
  WBC count                                                       Normal                        Low/normal
  Platelet count                                                  High/normal                   Low/normal
  Rheumatoid factor, anti-cyclic citrullinated peptide antibody   Positive                      Negative
  Anti-streptolysin O, anti-deoxyribonuclease-B                   Negative                      Negative
  Treatment                                                       NSAIDs, DMARDs, biologicals   NSAIDs

ESR: Erythrocyte sedimentation rate; CRP: C-reactive protein; WBC: White blood cell; NSAIDs: Nonsteroidal anti-inflammatory drugs; DMARDs: Disease-modifying antirheumatic drugs

Serum IgM antibody is recommended in the diagnosis of acute parvovirus B19 infection in immunocompetent hosts. This test has a sensitivity of 89% and specificity of 99%.\[[@ref10]\] IgG antibody testing is used for predicting progression of acute infection to chronic arthropathy.\[[@ref11]\] Demonstration of viral DNA is important for diagnosis in immunocompromised hosts.\[[@ref12][@ref13]\]

Primary care physicians are the first medical contact for most patients with such a presentation. At primary care level, physicians should generate a syndromic diagnosis followed by stepwise evaluation of differential diagnoses. The nonavailability of advanced diagnostic tests can be challenging in primary care settings. In such instances, resolution with symptomatic therapy prior to initiation of disease-modifying antirheumatic drugs would indicate viral arthritis.

This case highlights the uncommon presentation of acute parvovirus B19 infection mimicking rheumatoid arthritis. Although an exception rather than the rule, a high index of suspicion is crucial in making a timely diagnosis and avoiding untoward outcomes.
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